BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 27278104)

  • 1. Salvianolic Acid B Attenuates Experimental Pulmonary Fibrosis through Inhibition of the TGF-β Signaling Pathway.
    Liu Q; Chu H; Ma Y; Wu T; Qian F; Ren X; Tu W; Zhou X; Jin L; Wu W; Wang J
    Sci Rep; 2016 Jun; 6():27610. PubMed ID: 27278104
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Salvianolic acid B attenuates experimental skin fibrosis of systemic sclerosis.
    Liu Q; Lu J; Lin J; Tang Y; Pu W; Shi X; Jiang S; Liu J; Ma Y; Li Y; Xu J; Jin L; Wang J; Wu W
    Biomed Pharmacother; 2019 Feb; 110():546-553. PubMed ID: 30530290
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anti-Fibrosis Effects of Magnesium Lithospermate B in Experimental Pulmonary Fibrosis: By Inhibiting TGF-βRI/Smad Signaling.
    Luo X; Deng Q; Xue Y; Zhang T; Wu Z; Peng H; Xuan L; Pan G
    Molecules; 2021 Mar; 26(6):. PubMed ID: 33808650
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tanshinone IIA ameliorates bleomycin-induced pulmonary fibrosis and inhibits transforming growth factor-beta-β-dependent epithelial to mesenchymal transition.
    Tang H; He H; Ji H; Gao L; Mao J; Liu J; Lin H; Wu T
    J Surg Res; 2015 Jul; 197(1):167-75. PubMed ID: 25911951
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Honokiol: A polyphenol neolignan ameliorates pulmonary fibrosis by inhibiting TGF-β/Smad signaling, matrix proteins and IL-6/CD44/STAT3 axis both in vitro and in vivo.
    Pulivendala G; Bale S; Godugu C
    Toxicol Appl Pharmacol; 2020 Mar; 391():114913. PubMed ID: 32032644
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Salvianolic acid B attenuates experimental pulmonary inflammation by protecting endothelial cells against oxidative stress injury.
    Liu Q; Shi X; Tang L; Xu W; Jiang S; Ding W; Feng Q; Chu H; Ma Y; Li Y; Lu J; Pu W; Zhou X; Jin L; Wang J; Wu W
    Eur J Pharmacol; 2018 Dec; 840():9-19. PubMed ID: 30273543
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Peptide PD29 treats bleomycin-induced pulmonary fibrosis by inhibiting the TGF-β/smad signaling pathway.
    Sun Q; Hu J; Yu P; Zhu Z; Yu R; Ge C; Li C; Wu G; Lin B; Liu G; Liu M; Bian H; Xu H; Jia S
    Exp Lung Res; 2019; 45(5-6):123-134. PubMed ID: 31210057
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sunitinib, a Small-Molecule Kinase Inhibitor, Attenuates Bleomycin-Induced Pulmonary Fibrosis in Mice.
    Huang X; Wang W; Yuan H; Sun J; Li L; Wu X; Luo J; Gu Y
    Tohoku J Exp Med; 2016 Aug; 239(4):251-61. PubMed ID: 27439438
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dissection of the mechanism of traditional Chinese medical prescription-Yiqihuoxue formula as an effective anti-fibrotic treatment for systemic sclerosis.
    Wu T; Chu H; Tu W; Song M; Chen D; Yuan J; Yu L; Ma Y; Liu Q; Jin L; Zhou X; Zou H; Wu W; Wang J
    BMC Complement Altern Med; 2014 Jul; 14():224. PubMed ID: 24998426
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Emodin ameliorates bleomycin-induced pulmonary fibrosis in rats by suppressing epithelial-mesenchymal transition and fibroblast activation.
    Guan R; Wang X; Zhao X; Song N; Zhu J; Wang J; Wang J; Xia C; Chen Y; Zhu D; Shen L
    Sci Rep; 2016 Oct; 6():35696. PubMed ID: 27774992
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protective role of rhapontin in experimental pulmonary fibrosis in vitro and in vivo.
    Tao L; Cao J; Wei W; Xie H; Zhang M; Zhang C
    Int Immunopharmacol; 2017 Jun; 47():38-46. PubMed ID: 28364627
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of Plasminogen Activator Inhibitor-1 Attenuates Transforming Growth Factor-β-Dependent Epithelial Mesenchymal Transition and Differentiation of Fibroblasts to Myofibroblasts.
    Omori K; Hattori N; Senoo T; Takayama Y; Masuda T; Nakashima T; Iwamoto H; Fujitaka K; Hamada H; Kohno N
    PLoS One; 2016; 11(2):e0148969. PubMed ID: 26859294
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Compound Astragalus and Salvia miltiorrhiza extract inhibits cell proliferation, invasion and collagen synthesis in keloid fibroblasts by mediating transforming growth factor-β / Smad pathway.
    He S; Yang Y; Liu X; Huang W; Zhang X; Yang S; Zhang X
    Br J Dermatol; 2012 Mar; 166(3):564-74. PubMed ID: 21967214
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HYDAMTIQ, a selective PARP-1 inhibitor, improves bleomycin-induced lung fibrosis by dampening the TGF-β/SMAD signalling pathway.
    Lucarini L; Durante M; Lanzi C; Pini A; Boccalini G; Calosi L; Moroni F; Masini E; Mannaioni G
    J Cell Mol Med; 2017 Feb; 21(2):324-335. PubMed ID: 27704718
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prostaglandin F(2alpha) receptor signaling facilitates bleomycin-induced pulmonary fibrosis independently of transforming growth factor-beta.
    Oga T; Matsuoka T; Yao C; Nonomura K; Kitaoka S; Sakata D; Kita Y; Tanizawa K; Taguchi Y; Chin K; Mishima M; Shimizu T; Narumiya S
    Nat Med; 2009 Dec; 15(12):1426-30. PubMed ID: 19966781
    [TBL] [Abstract][Full Text] [Related]  

  • 16. EM703 improves bleomycin-induced pulmonary fibrosis in mice by the inhibition of TGF-beta signaling in lung fibroblasts.
    Li YJ; Azuma A; Usuki J; Abe S; Matsuda K; Sunazuka T; Shimizu T; Hirata Y; Inagaki H; Kawada T; Takahashi S; Kudoh S; Omura S
    Respir Res; 2006 Jan; 7(1):16. PubMed ID: 16438734
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel formononetin-7-sal ester ameliorates pulmonary fibrosis via MEF2c signaling pathway.
    Zhao X; Qu G; Song C; Li R; Liu W; Lv C; Song X; Zhang J; Li M
    Toxicol Appl Pharmacol; 2018 Oct; 356():15-24. PubMed ID: 29990528
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anti-pulmonary fibrotic activity of salvianolic acid B was screened by a novel method based on the cyto-biophysical properties.
    Liu M; Zheng M; Xu H; Liu L; Li Y; Xiao W; Li J; Ma E
    Biochem Biophys Res Commun; 2015 Dec 4-11; 468(1-2):214-20. PubMed ID: 26523510
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protective effect of peptide DR8 on bleomycin-induced pulmonary fibrosis by regulating the TGF-β/MAPK signaling pathway and oxidative stress.
    Wang D; Yan Z; Bu L; An C; Deng B; Zhang J; Rao J; Cheng L; Zhang J; Zhang B; Xie J
    Toxicol Appl Pharmacol; 2019 Nov; 382():114703. PubMed ID: 31398421
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Imatinib mesylate inhibits the profibrogenic activity of TGF-beta and prevents bleomycin-mediated lung fibrosis.
    Daniels CE; Wilkes MC; Edens M; Kottom TJ; Murphy SJ; Limper AH; Leof EB
    J Clin Invest; 2004 Nov; 114(9):1308-16. PubMed ID: 15520863
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.